Luye Pharma Group Ltd.
Clinical trials sponsored by Luye Pharma Group Ltd., explained in plain language.
Luye Pharma Group is a pharmaceutical company focused on drugs and complex formulations.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New pill aims to quiet the constant worry of anxiety disorder
Symptom relief CompletedThis study tests whether a new medication, toludesvenlafaxine, can safely reduce anxiety symptoms in adults with generalized anxiety disorder. Participants receive either a low dose, a high dose, or a placebo pill daily for 8 weeks. The main goal is to see if the drug lowers anxi…
Phase 3 • Sponsor: Luye Pharma Group Ltd. • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New drug LY03015 tested for safety in healthy people
Knowledge-focused CompletedThis early-phase trial tested the safety and how the body processes a new drug called LY03015 in 24 healthy adults from Chinese and Caucasian backgrounds. Participants took a single dose and were monitored for about a month. The study is complete and focused on gathering basic sa…
Phase 1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC